Tag: evogene

Learnings from the Earnings – Who’s Up? Who’s Down?

Learnings from the Earnings – Who’s Up? Who’s Down?

March 23, 2019 |

The lucky 13 – with spring comes a sense of renewal and this season these lucky 13 bioeconomy bellwethers recently shared their 2018 and Q4 earnings to reveal uncertainties with trade wars, especially between the U.S. and China, some deals that fell through impacting losses, and pricing issues. But all is not lost as there […]

Read More

Evogene Reports Third Quarter 2018 Financial Results

Evogene Reports Third Quarter 2018 Financial Results

November 18, 2018 |

In Israel, Evogene Ltd.’s financial results for the third quarter ending September 30, 2018 were positive with approximately $58.2 million in cash, short-term bank deposits and marketable securities, representing a net cash usage of approximately $13.5 million for the first nine months of 2018 and approximately $4.0 for the third quarter of 2018. Gross profit […]

Read More

‘Breakthrough’ harvesting solution, growing market, potential beyond biodiesel – all good signs for castor oil’s future

‘Breakthrough’ harvesting solution, growing market, potential beyond biodiesel – all good signs for castor oil’s future

November 18, 2018 |

A ‘breakthrough’ mechanical harvesting solution for castor bean plants was developed by Evogene and agricultural equipment manufacturer, Fantini s.r.l., resulting in the removal of a major bottleneck in the conversion of castor beans into a fully modernized commercial crop. With field trial yield losses decreasing significantly (we are talkin’ up to 50% decrease) as a […]

Read More

Evogene bio-stimulant microbial seed treatment trials a success in second year

Evogene bio-stimulant microbial seed treatment trials a success in second year

January 16, 2018 |

In Israel, Evogene recently announced highly promising second-year field trial results for its bio-stimulant microbial seed treatments for the improvement of corn yield, which are under exclusive license to DuPont Pioneer. The bio-stimulant seed treatments tested in these recent trials conducted by Evogene demonstrated up to 20 percent increases in corn yield under moderate drought conditions. […]

Read More

Earnings season: An advanced bioecononomy’s health and wellness check-up

Earnings season: An advanced bioecononomy’s health and wellness check-up

August 14, 2017 |

In today’s Digest, let’s look at trends driving the industry’s results at scale — and while money is not the measure of all progress, it is the ultimate yardstick and especially for companies that have reached industrial scale. So, let’s look at Q2 earnings statements now just coming out from four of the sector’s signature […]

Read More

Evogene reports Q2 financial results with $1.2M total revenues

Evogene reports Q2 financial results with $1.2M total revenues

August 12, 2017 |

In Israel, Evogene Ltd. announced total revenues for the second quarter of 2017 of $1.2 million, compared to $1.8 million for the second quarter in 2016. The decline in revenues reflects the net decrease in research and development cost reimbursement, in accordance with the work plans under Evogene’s various collaboration agreements, according to their press […]

Read More

DuPont Pioneer teams with Evogene on microbiome-based seed treatments in corn

DuPont Pioneer teams with Evogene on microbiome-based seed treatments in corn

August 7, 2017 |

In Iowa, DuPont Pioneer and Evogene Ltd announced that they have entered into a multiyear collaboration. The scope of the agreement includes the research and development of microbiome-based seed treatments in corn. The goal of the collaboration is to provide farmers with innovative bio-stimulant seed treatment products that protect and maximize corn yield by leveraging […]

Read More

Evogene hits milestones in crop disease tie up with Monsanto

Evogene hits milestones in crop disease tie up with Monsanto

July 11, 2017 |

In Israel, Evogene Ltd. announced it had reached an important milestone in its crop disease collaboration with Monsanto Company with the demonstration of positive Fusarium resistance results with Evogene discovered genes. Additionally, Evogene announced the completion of the candidate gene discovery stage in the companies’ yield and abiotic stress collaboration, which mainly focuses on corn […]

Read More

Evogene advances against Western corn rootworm

Evogene advances against Western corn rootworm

June 26, 2017 |

In Israel, Evogene has advanced a gene displaying insecticidal activity against Western corn rootworm into Phase-I  focusing on validation in target crops, following positive laboratory assay results. Additionally, the company announced for the first time the identification of a set of genes displaying initial toxic activity against southern green stinkbug, a major pest in soybean […]

Read More

Evogene reports declining revenue as focus shifts from gene discovery to pre-development

Evogene reports declining revenue as focus shifts from gene discovery to pre-development

May 21, 2017 |

In Israel, Evogene reported $83.4 million in cash, short-term bank deposits and marketable securities, as compared to $88.2 million at December 31, 2016 and reported revenues for the first quarter of 2017 of $0.7 million, compared to $2.0 million for the first quarter of 2016.  The net loss for the first quarter of 2017 was […]

Read More